CPH •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/08/2026 16:59
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeCPH
Market Capitalization1,321,132 mln
Float3,173 mln
Earnings Date11/04/2026
EPS
26.24
Exceptional
P / E
11.16
Fair value
1-Year Forecast
310
Modest upside
Relative Strength
7
/ 100
Severely lagging
Debt / Equity
0.63
Moderate leverage
ROE
59.81
Exceptional
Business Description
Founded in 1923 and based in Denmark, Novo Nordisk is a global pharmaceutical company best known for its treatments targeting diabetes and obesity, as well as a range of rare conditions affecting blood, hormones, and growth. The company develops and sells medicines, smart insulin delivery devices, and digital dosing tools, serving patients across North America, Europe, Asia, Latin America, and beyond.
